| Overview |
| bsm-61374r-pe-cy5-100ul |
| CD247 Recombinant Antibody, PE-Cy5 Conjugated |
| FCM |
| Human |
| Specifications |
| PE-Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CD247 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 919 |
| P20963 |
| Cell membrane |
| CD3-zeta; T-cell receptor T3 zeta chain; T3Z; TCRZ; CD247. |
| Defects in CD3D are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)/B(+)/NK(+) SCID). A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. |
| Application Dilution |
| FCM |
1:20-100 |
Powered by Bioz